Otrivin 0.1% 10 ml nasal spray metered menthol and CG.
- $6.40
The instruction
for medical use
of OTRIVIN® medicine
the Trade name
of Otrivin®
the International unlicensed
name Xylomethazolinum Dosage Form Spray the nasal
Structure
of 1 ml of solution dosed 0.1% with menthol and an eucalyptus, 10 ml contains
active agent - xylomethazolinum a hydrochloride of 1 mg,
excipients: dihydrophosphate sodium a dihydrate, hydrophosphate dinatrium dodecahydrate, sodium chloride, a benzalkoniya chloride, dinatrium edetat, left menthol, cineole, sorbitol, castor oil, polioksit hydrogenated (RH 40 cremophore), water cleaned.
The description
Opalescent solution of white color with a smell of menthol and an eucalyptus.
Pharmacotherapeutic group
of Antikongestanta and other nasal drugs for topical administration.
Sympathomimetics.
The code of automatic telephone exchange R01AA07
Pharmacological
Otrivin® properties belongs to group of local vasoconstrictors (decongestants) with a-adrenomimeticheskim action which is shown by narrowing of blood vessels of mucous and leads to elimination of hypostasis and
hyperaemia of a mucous membrane of a nose and nasopharynx and facilitates nasal breath in rhinitises.
The menthol and an eucalyptus which are contained in drug have the cooling effect on a mucous membrane of a nose.
In therapeutic doses does not irritate mucous, does not cause hyperaemia. Pharmacological action comes in a few minutes and continues within several hours.
Indications
- acute respiratory diseases with the phenomena of rhinitis (cold)
- acute allergic rhinitis
- a pollinosis
- sinusitis
- an eustachitis
- average otitis (for reduction of hypostasis of a mucous nasopharynx)
- allergic diseases of a nasal cavity and throat
- training of the patient for diagnostic manipulations in the nasal courses.
Route of administration and
Intranazalno's doses.
adults and children are more senior than 12 years: On 1 injection in each nasal course with an interval of 8-10 hours.
It is not necessary to use drug more than 3 times a day and also it is not necessary to apply more than 10 days.
Side effect
Is frequent
- a headache
- irritation and/or dryness of a mucous membrane of a nasopharynx, burning, sneezing, hypersecretion
Seldom
- reactions of hypersensitivity (Quincke's edema, urticaria, an itching)
- a rhinedema
- a disorder of vision
- heartbeat, tachycardia, arrhythmias, increase in arterial blood pressure
- nausea
- insomnia
- a depression (at prolonged use of high doses)
Contraindications to use
- hypersensitivity to xylomethazolinum or any other component of drug
- arterial hypertension
- tachycardia
- the profound atherosclerosis
- glaucoma
- atrophic rhinitis
- a hyperthyroidism
- surgical interventions on a meninx (in the anamnesis)
- children's age up to 12 years
- pregnancy and the period of a lactation
With care – in diabetes.
Medicinal interactions
It is incompatible with MAO inhibitors and tricyclic antidepressants
the Special
instructions Otrivin®, as well as other sympathomimetic means, it is necessary to appoint with care to patients at whom at use of adrenergic drugs, the strong reactions which are expressed as insomnia, dizziness, a tremor, disturbance of a warm rhythm or increase in arterial blood pressure are noted.
Drug should not be used for a long time, for example, in chronic rhinitis.
There are no sufficient data on action of Otrivina® on fertility. As system influence of xylomethazolinum of a hydrochloride is very low, its influence on fertility is improbable.
Features of influence of medicine on ability to run the vehicle or potentially dangerous
Otrivin® mechanisms in the dosages exceeding recommended can influence ability to run the vehicle or potentially dangerous mechanisms.
Overdose
Symptoms: strengthening of side effects.
Treatment is symptomatic.
The form of release and packing
On 10 ml place in bottles from polyethylene of high density, with a protective cap and the pipette from polyethylene with a nozzle from chlorbutyl elastomer.
On a bottle paste the label self-adhesive.
On 1 bottle together with the instruction for medical use in the state and Russian languages place in a pack from cardboard.
To Store storage conditions at a temperature not above + 25 °C
to Store out of children's reach!
2.5 years
not to use a period of storage after the date specified on packing.
Prescription status
Without prescription
the Name and the country
of the Novartis Konsyyumer Hels SA manufacturing organization, Switzerland
the Name and the country of the owner of the registration certificate
of Novartis Konsyyumer Hels SA, Switzerland
the Name and the country
of the Novartis Konsyyumer Hels SA organization packer, Switzerland
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from the consumer on quality
of the Novartis Pharm Services AG Branch product in RK
Almaty, Zhamakayev St., 155 A
ph. (727) 258-12-91
fax: (727) 250-64-63
http://iws-pharma.na.novartis.net
for medical use
of OTRIVIN® medicine
the Trade name
of Otrivin®
the International unlicensed
name Xylomethazolinum Dosage Form Spray the nasal
Structure
of 1 ml of solution dosed 0.1% with menthol and an eucalyptus, 10 ml contains
active agent - xylomethazolinum a hydrochloride of 1 mg,
excipients: dihydrophosphate sodium a dihydrate, hydrophosphate dinatrium dodecahydrate, sodium chloride, a benzalkoniya chloride, dinatrium edetat, left menthol, cineole, sorbitol, castor oil, polioksit hydrogenated (RH 40 cremophore), water cleaned.
The description
Opalescent solution of white color with a smell of menthol and an eucalyptus.
Pharmacotherapeutic group
of Antikongestanta and other nasal drugs for topical administration.
Sympathomimetics.
The code of automatic telephone exchange R01AA07
Pharmacological
Otrivin® properties belongs to group of local vasoconstrictors (decongestants) with a-adrenomimeticheskim action which is shown by narrowing of blood vessels of mucous and leads to elimination of hypostasis and
hyperaemia of a mucous membrane of a nose and nasopharynx and facilitates nasal breath in rhinitises.
The menthol and an eucalyptus which are contained in drug have the cooling effect on a mucous membrane of a nose.
In therapeutic doses does not irritate mucous, does not cause hyperaemia. Pharmacological action comes in a few minutes and continues within several hours.
Indications
- acute respiratory diseases with the phenomena of rhinitis (cold)
- acute allergic rhinitis
- a pollinosis
- sinusitis
- an eustachitis
- average otitis (for reduction of hypostasis of a mucous nasopharynx)
- allergic diseases of a nasal cavity and throat
- training of the patient for diagnostic manipulations in the nasal courses.
Route of administration and
Intranazalno's doses.
adults and children are more senior than 12 years: On 1 injection in each nasal course with an interval of 8-10 hours.
It is not necessary to use drug more than 3 times a day and also it is not necessary to apply more than 10 days.
Side effect
Is frequent
- a headache
- irritation and/or dryness of a mucous membrane of a nasopharynx, burning, sneezing, hypersecretion
Seldom
- reactions of hypersensitivity (Quincke's edema, urticaria, an itching)
- a rhinedema
- a disorder of vision
- heartbeat, tachycardia, arrhythmias, increase in arterial blood pressure
- nausea
- insomnia
- a depression (at prolonged use of high doses)
Contraindications to use
- hypersensitivity to xylomethazolinum or any other component of drug
- arterial hypertension
- tachycardia
- the profound atherosclerosis
- glaucoma
- atrophic rhinitis
- a hyperthyroidism
- surgical interventions on a meninx (in the anamnesis)
- children's age up to 12 years
- pregnancy and the period of a lactation
With care – in diabetes.
Medicinal interactions
It is incompatible with MAO inhibitors and tricyclic antidepressants
the Special
instructions Otrivin®, as well as other sympathomimetic means, it is necessary to appoint with care to patients at whom at use of adrenergic drugs, the strong reactions which are expressed as insomnia, dizziness, a tremor, disturbance of a warm rhythm or increase in arterial blood pressure are noted.
Drug should not be used for a long time, for example, in chronic rhinitis.
There are no sufficient data on action of Otrivina® on fertility. As system influence of xylomethazolinum of a hydrochloride is very low, its influence on fertility is improbable.
Features of influence of medicine on ability to run the vehicle or potentially dangerous
Otrivin® mechanisms in the dosages exceeding recommended can influence ability to run the vehicle or potentially dangerous mechanisms.
Overdose
Symptoms: strengthening of side effects.
Treatment is symptomatic.
The form of release and packing
On 10 ml place in bottles from polyethylene of high density, with a protective cap and the pipette from polyethylene with a nozzle from chlorbutyl elastomer.
On a bottle paste the label self-adhesive.
On 1 bottle together with the instruction for medical use in the state and Russian languages place in a pack from cardboard.
To Store storage conditions at a temperature not above + 25 °C
to Store out of children's reach!
2.5 years
not to use a period of storage after the date specified on packing.
Prescription status
Without prescription
the Name and the country
of the Novartis Konsyyumer Hels SA manufacturing organization, Switzerland
the Name and the country of the owner of the registration certificate
of Novartis Konsyyumer Hels SA, Switzerland
the Name and the country
of the Novartis Konsyyumer Hels SA organization packer, Switzerland
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from the consumer on quality
of the Novartis Pharm Services AG Branch product in RK
Almaty, Zhamakayev St., 155 A
ph. (727) 258-12-91
fax: (727) 250-64-63
http://iws-pharma.na.novartis.net
Related Products
